Ingredient Audit
Pygeum for Prostate Symptoms: What 18 Trials Found — and Why the Label Rarely Matches Them
Pygeum is the quiet second-best evidence file in this category: an 18-trial Cochrane review, a specific benefit for the nighttime trips that drive men to buy anything at all, and almost no marketing budget behind it. It also comes with the category's messiest label problem, because "pygeum" can mean very different extracts in very different amounts. Both halves of that story are below.
Disclosure: this page links to product reviews that carry affiliate links, and we may earn a commission at no cost to you. Our ingredient assessments follow our published methodology and are not for sale. Full disclosure.
The short answer
Pygeum — an extract of the bark of the African prune tree — ranks second in our ingredient audit, behind only beta-sitosterol. The Cochrane review pooled 18 randomized trials and 1,562 men and found that men taking pygeum were more than twice as likely to report improvement in their urinary symptoms, with nighttime urination down 19%, leftover bladder volume down 24%, and peak urine flow up 23% versus placebo. Now the part the sales pages leave off: those trials were small, short, used varied doses and preparations, and often did not use validated symptom scales. Good evidence, honestly hedged — which still puts it ahead of almost everything else in this category.
What the evidence actually shows
The source is the Cochrane review by Wilt and colleagues (2002), available in full via the PMC archive, with the underlying meta-analysis indexed at PubMed. Eighteen randomized controlled trials, 1,562 men with symptomatic BPH. The headline results:
- Overall improvement: more than 2× as likely to be reported by men on pygeum versus placebo — the single most patient-relevant number in the review.
- Nocturia: −19%. Nighttime trips are the symptom men rank worst in the buyer reports we reviewed, and this is the clearest ingredient-specific signal for it in the category.
- Post-void residual volume: −24%. Less urine left behind after going — the mechanical basis for feeling finished instead of "done but not done."
- Peak urine flow: +23%. An objective measurement moving in the right direction, consistent with the symptom reports.
Now the caveats, printed at the same size as the claims, because the review itself insists on them. The trials were small and short. They used varied doses and varied preparations — different extracts, different regimens — so there is no single "pygeum dose" the way there nearly is for beta-sitosterol. And many of the older trials did not use validated symptom scales, which makes their results harder to compare with modern studies. A fair summary: the direction of the evidence is consistently positive across 18 trials, and the precision of the evidence is weaker than the headline numbers look. That combination earns pygeum its #2 ranking — and its label problem, which comes next.
One more fact that belongs in an honest audit: pygeum comes from the bark of the African prune tree (Prunus africana), and commercial demand has put real harvesting pressure on the species. Bark stripping can kill the tree, and the trade is regulated for that reason. A brand that can document where its bark comes from — cultivated or sustainably harvested sources, named on the label or the vendor's materials — is showing you something real. Documented sourcing is a green flag. Silence about sourcing is not proof of bad sourcing, but it is one more thing the label declined to tell you.
Studied dose vs. label dose
| Preparation / form | Studied amount | What typical product labels show | The gap |
|---|---|---|---|
| Standardized pygeum bark extract (the common trial preparation) | 50 mg twice daily (100 mg/day) was a common trial regimen | Anything from a named extract with mg printed to "pygeum" buried in a proprietary blend with no amount at all | Unknowable on blend labels. 100 mg/day of extract and a token dusting print identically when the mg are hidden. |
| Non-standardized bark powder / crude bark | Not the preparation the trial base rests on | Sometimes sold by weight (hundreds of mg of powder), which looks like "more" than 100 mg of extract | An apples-to-orchards comparison. Milligrams of crude bark are not milligrams of extract; the bigger number can be the weaker product. |
| Extracts of unstated strength / ratio | Trials at least identified their preparations | An extract mg figure with no standardization or extract ratio stated | Half a disclosure. You know the weight of the extract, not what is in the extract. |
Dataset: Men's Supplement Studied-Dose Benchmarks (November 2026) — the studied amounts above are the doses used in the published trials cited on this page; label amounts are as printed on vendor labels at audit. This is one of four ingredient benchmark tables; the set is summarized on How We Review.
This is why pygeum is the hardest ingredient in the category to buy well. With beta-sitosterol, the audit question is one number. With pygeum, it is three: how much, of what extract, from where. Labels that answer all three exist. Labels that answer none of them are asking for trust they have not earned — and in a category where independent testing has caught products delivering less than half their claimed contents (see third-party testing), trust is not a substitute for print.
Which reviewed products contain it — and what their labels disclose
ProstaVive includes pygeum in its botanical blend — alongside saw palmetto and stinging nettle, under a colostrum headline. The blend format means the per-ingredient pygeum amount is not disclosed on the materials we audited: pygeum is present, its dose is a live-label question, and until a figure is published, no buyer can hold ProstaVive's pygeum against the 50 mg twice-daily trial regimen. We rank ProstaVive #1 overall on its package — guarantee, powder format, demand — not on dose transparency.
TitanFlow lists pygeum on its label as part of the category's most complete formula — beta-sitosterol leading, pygeum in the supporting cast, alongside pomegranate extract, boron, and saw palmetto. Its exact pygeum amount and extract specification are likewise undisclosed. TitanFlow is the label we respect most of the four in our comparison, and even there, pygeum is the line item where the label tells you the least relative to what the trials used.
That pattern — ingredient present, dose undisclosed — is the category norm, not a ProstaVive or TitanFlow scandal. We print it the same way on every page: where a label hides milligrams inside a proprietary blend, the honest sentence is that the dose cannot be verified, and our scores weight that.
Safety & interactions
Across the trials, pygeum was generally well tolerated; mild gastrointestinal complaints — stomach upset, occasional nausea — were the most commonly reported side effects, and discontinuations were uncommon. The honest limit: the trials were short, so long-term safety data is thinner than for the prescription alternatives, and "used traditionally for decades" is a history claim, not a safety trial. If you take prescription medication, including BPH medication or blood thinners, raise any new supplement with your doctor first. And if nighttime urination is new, worsening, or paired with other symptoms, get it evaluated — nocturia has causes beyond the prostate, and a bark extract addresses none of them.
Our verdict: who should look for it
Look for pygeum if nighttime trips are your headline symptom — it has the most specific nocturia signal of any ingredient in this category, inside a formula whose other ingredients carry their own weight (it is a supporting player, and the two reviewed formulas above both use it that way). Insist on the fuller disclosure where you can get it: a named extract, milligrams printed, sourcing documented. Skip any product whose entire pygeum story is the word "pygeum" inside a blend total. Eighteen trials say the ingredient deserves better than that — and so does your money.
The rest of the bench: beta-sitosterol (the #1 evidence file), pumpkin seed extract (where the whole food beat the capsule), saw palmetto (the most marketed, least proven), and third-party testing — how to check whether a bottle contains what its label claims. Pygeum inside the full category picture: prostate supplements compared.
Citing this data: you may quote and cite the figures on this page with attribution to Men's Supplement (menssupplement.org) and a link to this page. Methodology: How We Review.
Frequently Asked Questions
What dose of pygeum did the studies use?
Doses varied across the 18 trials in the Cochrane review, because the extracts varied. A common trial regimen was 50 mg twice daily (100 mg/day total) of a standardized bark extract. Because extracts are not interchangeable, a label that prints milligrams without identifying the extract tells you less than it appears to.
Is pygeum especially good for nighttime urination?
That is its strongest signal. In the Cochrane review, nocturia (nighttime trips) fell by 19% versus placebo, alongside a 24% reduction in leftover bladder volume and a 23% improvement in peak flow. Men were also more than twice as likely to report overall improvement.
Does pygeum shrink the prostate?
No claim like that survives the review. The measured benefits were symptoms and flow — how you feel and how you empty — not gland size. Treat any "shrinks your prostate" copy attached to pygeum as marketing, not medicine.
Why do pygeum labels differ so much from each other?
Because "pygeum" on a label can mean different bark extracts at different strengths, and there is no single standard every brand follows. The trials themselves used varied preparations, which is one of the review's stated caveats. Documented, standardized sourcing is the green flag to look for.
Is pygeum safe?
In the trials it was generally well tolerated, with mild stomach upset the most common complaint. The trials were short, though, so long-term safety data is thinner than the marketing suggests. If you take prescription medication, check with your doctor first, as with any supplement.
Written under our published methodology. Prices and terms change — we re-check them against the live vendor pages on each audit pass. Corrections: contact us.